{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:14:26Z","timestamp":1780586066375,"version":"3.54.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"La Roche-Posay Laboratoire Dermatologique"},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s13555-026-01775-1","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:24:34Z","timestamp":1777461874000},"page":"3065-3078","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Prebiotic and Panthenol-Containing Repair Balm Improves Tolerability of Topical 5-Fluorouracil Field Therapy for Actinic Keratoses: A Randomised Controlled Trial"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4787-0934","authenticated-orcid":false,"given":"Anne","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel X.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwige","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Kerob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiarash","family":"Khosrotehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"3","key":"1775_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jid.2016.10.024","volume":"137","author":"LG Gordon","year":"2017","unstructured":"Gordon LG, Elliott TM, Olsen CM, Pandeya N, Whiteman DC. Multiplicity of skin cancers in Queensland and their cost burden. J Investig Dermatol. 2017;137(3):709\u201315. https:\/\/doi.org\/10.1016\/j.jid.2016.10.024.","journal-title":"J Investig Dermatol"},{"issue":"3","key":"1775_CR2","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/bjd.12443","volume":"169","author":"RN Werner","year":"2013","unstructured":"Werner RN, Sammain A, Erdmann R, et\u00a0al. The natural history of actinic keratosis: a systematic review. Br J Dermatol. 2013;169(3):502\u201318. https:\/\/doi.org\/10.1111\/bjd.12443.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1775_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/jamadermatol.2017.3631","volume":"154","author":"MA Weinstock","year":"2018","unstructured":"Weinstock MA, et\u00a0al. Chemoprevention of basal and squamous cell carcinoma with a single course of fluorouracil 5% cream: a randomized clinical trial. JAMA Dermatol. 2018;154(2):167\u201374. https:\/\/doi.org\/10.1001\/jamadermatol.2017.3631.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"1775_CR4","first-page":"22","volume":"1","author":"WP Werschler","year":"2008","unstructured":"Werschler WP. Considerations for use of fluorouracil cream 0.5% for the treatment of actinic keratosis in elderly patients. J Clin Aesthet Dermatol. 2008;1(2):22\u20137.","journal-title":"J Clin Aesthet Dermatol."},{"issue":"10","key":"1775_CR5","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1056\/NEJMoa1811850","volume":"380","author":"MHE Jansen","year":"2019","unstructured":"Jansen MHE, Kessels JPHM, Nelemans PJ, Kouloubis N, Arits AHMM, van Pelt HPA, et\u00a0al. Randomized trial of four treatment approaches for actinic keratosis. N Engl J Med. 2019;380(10):935\u201346. https:\/\/doi.org\/10.1056\/NEJMoa1811850.","journal-title":"N Engl J Med"},{"issue":"5","key":"1775_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1365-4632.2009.04045.x","volume":"48","author":"DA Askew","year":"2009","unstructured":"Askew DA, Mickan SM, Soyer HP, Wilkinson D. Effectiveness of 5-fluorouracil treatment for actinic keratosis: a systematic review of randomized controlled trials. Int J Dermatol. 2009;48(5):453\u201363. https:\/\/doi.org\/10.1111\/j.1365-4632.2009.04045.x.","journal-title":"Int J Dermatol"},{"issue":"2","key":"1775_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s13555-014-0059-9","volume":"4","author":"R Rosen","year":"2014","unstructured":"Rosen R, Marmur E, Anderson L, Welburn P, Katsamas J. A new, objective, quantitative scale for measuring local skin responses following topical actinic keratosis therapy. Dermatol Ther (Heidelb). 2014;4(2):207\u201319. https:\/\/doi.org\/10.1007\/s13555-014-0059-9.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"4","key":"1775_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13533","volume":"33","author":"W Li","year":"2020","unstructured":"Li W, Yu Q, Shen Z, et\u00a0al. Effects of a cream containing madecassoside, 5% panthenol, and copper-zinc-manganese on postlaser wound healing: a randomized trial. Dermatol Ther. 2020;33(4):e13533. https:\/\/doi.org\/10.1111\/dth.13533.","journal-title":"Dermatol Ther"},{"issue":"1","key":"1775_CR9","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.5826\/dpc.1501a4905","volume":"15","author":"C Ariasi","year":"2025","unstructured":"Ariasi C, Roman\u00f2 C, Tomasi C, et\u00a0al. Prebiotic- and panthenol-containing dermocosmetics post-cryotherapy for actinic keratoses: a randomized controlled trial. Dermatol Pract Concept. 2025;15(1):4905. https:\/\/doi.org\/10.5826\/dpc.1501a4905.","journal-title":"Dermatol Pract Concept"},{"key":"1775_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2024.104394","volume":"50","author":"G Fredman","year":"2024","unstructured":"Fredman G, Jacobsen K, Philipsen PA, Wiegell SR, Haedersdal M. Prebiotic and panthenol-containing dermocosmetic improves tolerance from daylight photodynamic therapy. Photodiagn Photodyn Ther. 2024;50:104394. https:\/\/doi.org\/10.1016\/j.pdpdt.2024.104394.","journal-title":"Photodiagn Photodyn Ther"},{"issue":"2","key":"1775_CR11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1684\/ejd.2025.4855","volume":"35","author":"S Gregoriou","year":"2025","unstructured":"Gregoriou S, Vakirlis E, Zafiriou E. Efficacy and tolerance of a prebiotic, panthenol-containing repair balm in regenerative care. Eur J Dermatol. 2025;35(2):118\u201326. https:\/\/doi.org\/10.1684\/ejd.2025.4855.","journal-title":"Eur J Dermatol"},{"key":"1775_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000441588","volume":"49","author":"A Gim\u00e9nez-Arnau","year":"2016","unstructured":"Gim\u00e9nez-Arnau A. Standards for the protection of skin barrier function. Curr Probl Dermatol. 2016;49:123\u201334.","journal-title":"Curr Probl Dermatol"},{"issue":"8","key":"1775_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.31128\/AJGP-09-24-7415","volume":"54","author":"J O\u2019Bryen","year":"2025","unstructured":"O\u2019Bryen J, Green S, Seine AJ, Hudson J, De Cruz R, Reiche L, et\u00a0al. Pre- and post-treatment care for actinic keratoses: an Australian and New Zealand perspective. Aust J Gen Pract. 2025;54(8):541\u20136. https:\/\/doi.org\/10.31128\/AJGP-09-24-7415.","journal-title":"Aust J Gen Pract"},{"issue":"1","key":"1775_CR14","doi-asserted-by":"publisher","first-page":"2487657","DOI":"10.1080\/09546634.2025.2487657","volume":"36","author":"T Dirschka","year":"2025","unstructured":"Dirschka T, Ardig\u00f2 M, Fargnoli MC, et\u00a0al. Reshaping treatment paradigm in actinic keratosis using a modified Delphi questionnaire. J Dermatol Treat. 2025;36(1):2487657. https:\/\/doi.org\/10.1080\/09546634.2025.2487657.","journal-title":"J Dermatol Treat"},{"issue":"2","key":"1775_CR15","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.5826\/dpc.1502a5787","volume":"15","author":"G Brancaccio","year":"2025","unstructured":"Brancaccio G, Briatico G, Apalla Z, et\u00a0al. Management of local skin reactions caused by 5-FU 4% cream: a Delphi consensus. Dermatol Pract Concept. 2025;15(2):5787. https:\/\/doi.org\/10.5826\/dpc.1502a5787.","journal-title":"Dermatol Pract Concept"},{"issue":"4","key":"1775_CR16","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s13555-023-00902-6","volume":"13","author":"E Stockfleth","year":"2023","unstructured":"Stockfleth E, Jouary T, Farnetani F, et\u00a0al. Severity of local skin reactions with 5-fluorouracil plus emollient versus 5-fluorouracil alone: a randomized trial. Dermatol Ther (Heidelb). 2023;13(4):1013\u201327. https:\/\/doi.org\/10.1007\/s13555-023-00902-6.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"1","key":"1775_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16610","volume":"24","author":"JM Amici","year":"2025","unstructured":"Amici JM, Le Dantec G, Demessant AL, et\u00a0al. A dermocosmetic balm improves post-laser recovery: a randomized intra-individual study. J Cosmet Dermatol. 2025;24(1):e16610. https:\/\/doi.org\/10.1111\/jocd.16610.","journal-title":"J Cosmet Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01775-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01775-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01775-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:53:29Z","timestamp":1780584809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01775-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1775"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01775-1","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kiarash Khosrotehrani has received consultancy and speaking fees from La Roche-Posay for unrelated projects. Suzanne Nguyen is employed by La Roche-Posay Laboratoire Dermatologique. Delphine Kerob is employed by La Roche-Posay Laboratoire Dermatologique. Anne Tseng, Regina Yu, Susan Brown, Nicholas Muller, Samuel X Tan and Edwige Roy have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Ethical approval was obtained from the relevant Human Research Ethics Committee (HREC; HREC\/2024\/QMS\/104804). This study was performed in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. All participants provided written informed consent prior to enrolment and for publication of clinical images. The trial was prospectively registered with the Australian New Zealand Clinical Trials Registry (ANZCTR; Trial Registration No. ACTRN12624000911594).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}